TG THERAPEUTICS, INC. (TGTX) Operating margin 2016–2025
TG THERAPEUTICS, INC. (TGTX) operating margin by fiscal year — reported operating income divided by reported revenue.
20.0%FY2025 · since FY2016: -51953.3% → 20.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 20.0% | +7.3 pp |
| FY2024 | 12.7% | +3.9 pp |
| FY2023 | 8.8% | +7847.8 pp |
| FY2022 | -7839.0% | -2684.7 pp |
| FY2021 | -5154.3% | +174841.8 pp |
| FY2020 | -179996.1% | -68775.7 pp |
| FY2019 | -111220.4% | +3516.4 pp |
| FY2018 | -114736.8% | -36636.8 pp |
| FY2017 | -78100.0% | -26146.7 pp |
| FY2016 | -51953.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice